Burton Katherine I, MacMillan David W C
Merck Center for Catalysis at Princeton University, Princeton, New Jersey 08544, United States.
Lead contact.
Chem. 2025 May 8;11(5). doi: 10.1016/j.chempr.2025.102537. Epub 2025 Apr 8.
The prevalence of benzene rings in pharmaceutical scaffolds has prompted efforts to identify structural bioisosteres with improved properties. Notably, bicyclo[1.1.1]pentanes (BCPs)-C(sp)-enriched, 1,4-disubstituted phenyl bioisosteres-have been leveraged to tune the pharmacokinetic profiles of lead compounds. While 3-arylated BCPs have been widely implemented to confer resistance against oxidative degradation and hydrogen atom transfer (HAT) processes, the analogous 3-alkylated BCPs remain underexplored as bioisosteric "benzylic" C-H motifs. Current methods to install 3-alkylated BCP motifs are heavily reliant on lengthy synthesis and the preparation of reactive [1.1.1]propellane feedstocks, limiting their adoption in drug discovery programs. In this report, we disclose a mild, unified method for the preparation of both alkyl and aryl-substituted BCPs from bench-stable precursors. This method, which proceeds via dual copper-photoredox catalysis, is capable of installing BCP functionalities onto a range of saturated motifs, aryl-containing residues, and medicinally relevant heterocycles.
药物骨架中苯环的普遍性促使人们努力寻找具有改进性质的结构生物电子等排体。值得注意的是,双环[1.1.1]戊烷(BCPs)——富含C(sp)的1,4-二取代苯基生物电子等排体——已被用于调节先导化合物的药代动力学特征。虽然3-芳基化的BCPs已被广泛应用于赋予对氧化降解和氢原子转移(HAT)过程的抗性,但类似的3-烷基化BCPs作为生物电子等排的“苄基”C-H基序仍未得到充分研究。目前安装3-烷基化BCP基序的方法严重依赖于冗长的合成和活性[1.1.1]丙烷原料的制备,限制了它们在药物发现计划中的应用。在本报告中,我们公开了一种从易于保存的前体中制备烷基和芳基取代的BCPs的温和、统一的方法。该方法通过双铜-光氧化还原催化进行,能够将BCP官能团安装到一系列饱和基序、含芳基残基和与药物相关的杂环上。